Get the Stockscreener App
6.66
2.63%
-0.18
Champions Oncology Inc stock is traded at $6.66, with a volume of 589.
It is down -2.63% in the last 24 hours and up +5.71% over the past month.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
See More
Previous Close:
$6.84
Open:
$6.7
24h Volume:
589
Relative Volume:
0.02
Market Cap:
$92.38M
Revenue:
$49.98M
Net Income/Loss:
$-9.64M
P/E Ratio:
-9.3803
EPS:
-0.71
Net Cash Flow:
$-4.86M
1W Performance:
-2.35%
1M Performance:
+5.71%
6M Performance:
+15.42%
1Y Performance:
+66.50%
1-Day Range:
$6.70
$6.70
1-Week Range:
$6.67
$6.90
52-Week Range:
$3.955
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology Inc
Sector
Industry
Phone
410-369-0365
Address
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.70 | 94.31M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.77 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
644.76 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.92 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
829.03 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.21 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-18-19 | Initiated | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Stock (CSBR) Latest News
What indicators show strength in Champions Oncology Inc.Swing Trade & Reliable Volume Spike Alerts - newser.com
Real time social sentiment graph for Champions Oncology Inc.2025 Major Catalysts & Safe Capital Growth Plans - newser.com
Why Champions Oncology Inc. (2I3) stock could rally stronglyMarket Activity Recap & Real-Time Stock Entry Alerts - newser.com
Candlestick signals on Champions Oncology Inc. stock todayWeekly Trend Summary & Consistent Growth Equity Picks - newser.com
What earnings margins imply for Champions Oncology Inc. (2I3) stockJuly 2025 Outlook & Long Hold Capital Preservation Plans - newser.com
Why analysts recommend Champions Oncology Inc. (2I3) stockMarket Sentiment Report & Verified Swing Trading Watchlist - newser.com
Will Champions Oncology Inc. (2I3) stock test record highs in 2025Earnings Miss & Breakout Confirmation Alerts - newser.com
Published on: 2025-11-02 03:57:30 - newser.com
Why Champions Oncology Inc. is moving todayJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - newser.com
Why pension funds invest in Champions Oncology Inc. (2I3) stockJuly 2025 Sector Moves & Reliable Entry Point Alerts - newser.com
Champions Oncology Inc 2I3 Stock Analysis and ForecastIndustrial Stocks Review & Consistent Double Returns - earlytimes.in
How Champions Oncology Inc. stock benefits from strong dollar2025 Stock Rankings & Growth Oriented Trading Recommendations - newser.com
Tick level data insight on Champions Oncology Inc. volatility2025 Retail Activity & Low Risk Entry Point Tips - newser.com
Is Champions Oncology Inc. showing signs of accumulationWeekly Trade Analysis & Stock Portfolio Risk Management - newser.com
Will Champions Oncology Inc. continue its uptrendJuly 2025 Sector Moves & Verified Short-Term Plans - newser.com
Published on: 2025-10-30 22:50:51 - newser.com
What Wall Street predicts for Champions Oncology Inc. stock priceJuly 2025 Snapshot & Low Drawdown Trading Techniques - fcp.pa.gov.br
What momentum indicators show for Champions Oncology Inc. stockTrade Entry Summary & Proven Capital Preservation Tips - Fundação Cultural do Pará
Champions Oncology Inc Stock (CSBR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):